NASDAQ:MRVI

Maravai Lifesciences Holdings Stock News

etoro logo Buy MRVI
*Your capital is at risk
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
MRVI earnings call for the period ending December 31, 2021.
Maravai LifeSciences Holdings, Inc. (MRVI) Carl Hull on Q4 2021 Results - Earnings Call Transcript
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and the full year ended December 31, 2021, together with other business updates. Recent highlights include:
Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 18.42% and 10.81%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahea
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
They're risky. But they could also be huge winners.

Maravai LifeSciences acquires MyChem for $240M

01:20pm, Friday, 28'th Jan 2022 Seeking Alpha
Maravai LifeSciences (MRVI) acquired San Diego-based MyChem for $240M in cash with the potential for additional contingent cash based on achievement of certain conditions.Privately
Maravai LifeSciences went public in November 2020, raising $1.62 billion in gross proceeds in a U.S. IPO.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators
Related Stocks: SBNY , UTHR , PANW , MRVI , ALB , CONE , TTD , BLMN , TFX , TWLO , FIVN , FL , OC , VFC ,

Maravai LifeSciences Added to the Nasdaq Biotechnology Index

01:30pm, Tuesday, 14'th Dec 2021 Intrado Digital Media
SAN DIEGO, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI) effective prior to market open on Monday, December 20, 2021.
Strs Ohio lowered its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) by 15.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 151,000 shares of the companys stock after selling 26,600 shares during the period. Strs Ohio owned about []
Virginia Retirement Systems ET AL bought a new stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 16,300 shares of the companys stock, valued at approximately $800,000. Other institutional investors have []
Wall Street analysts expect that Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) will post $206.15 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Maravai LifeSciences earnings. The lowest sales estimate is $204.20 million and the highest is $208.70 million. Maravai LifeSciences posted sales of $98.35 million in the []
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE